Deepening Global Collaboration, Renhe Capsule Makes a Splash at CPHI Europe 2025

From October 28 to 30, 2025, the premier global pharmaceutical industry event—CPHI Europe—was held in Frankfurt, Germany. As an outstanding representative of China’s medicinal capsule industry, Shaoxing Renhe Capsule Co., Ltd. showcased its full range of innovative products and solutions at the exhibition. The display demonstrated the exceptional quality and innovative capabilities of China’s pharmaceutical excipients sector to a global professional audience, resulting in multiple successful cooperation intentions secured during the event.

At the exhibition, Renhe Capsule’s booth attracted numerous international pharmaceutical companies, health product manufacturers, and industry experts with its professional presentation and high-quality products. Highlights included not only conventional gelatin and HPMC plant-based capsules compliant with European and American pharmacopoeia standards but also specialized offerings such as enteric-coated sustained-release capsules. Renhe’s technical team engaged in in-depth and productive exchanges with overseas clients on topics ranging from regulatory requirements across different markets to customized formulation needs and collaborative R&D initiatives.

“Europe is a benchmark market for the pharmaceutical industry. Participating in CPHI is a crucial step in advancing our globalization strategy,” stated Renhe Capsule’s International Sales Director at the event. “Through this exhibition, we have not only acquired new clients but, more importantly, strengthened trust with our long-term partners through face-to-face interactions and gained precise insights into the latest international market trends. We will continue to invest in R&D to ensure that Renhe’s capsule products meet the most stringent global quality standards.”

Driving Development Through Innovation, Earning Trust Through Quality

This participation was not only a showcase of products and technologies but also a comprehensive demonstration of Renhe Capsule’s corporate strength and international brand image. Adhering to its operational philosophy of “Benevolence as the Foundation, Harmony and Coexistence,” the company consistently regards product quality as its lifeline, having established an international quality management system that spans the entire chain from raw materials to production and testing. In response to global trends toward greener and smarter pharmaceutical solutions, Renhe Capsule has taken a leading role in developing environmentally friendly products such as plant-based capsules and TiO2-free capsules, while actively exploring intelligent manufacturing solutions. The company is committed to providing customers with safer, more reliable, and more sustainable capsule product options.

The success of this exhibition has further enhanced Renhe Capsule’s brand recognition in the international high-end market, laying a solid foundation for the company’s business expansion in Europe and globally. Moving forward, Renhe Capsule will continue to deepen collaboration with international partners, promoting the role of “Made in China” and Chinese quality within the global pharmaceutical supply chain, and contributing Chinese expertise to safeguarding human health.